TYLOGRAN WSP

Description

Tylogran WSP Indications: In Beef Cattle and Non-lactating Dairy Cattle, Tylogran WSP 100% 200 Injection is indicated for use in the treatment of bovine respiratory complex (shipping fever, pneumonia) usually associated with Pasteurella multocida and Arcanobacterium pyogenes; foot rot (necrotic pododermatitis) and calf diphtheria caused by Fusobacterium necrophorum and metritis caused by Arcanobacterium pyogenes.
In swine, Tylogran 100% 200 Injection is indicated for use in the treatment of swine arthritis caused by Mycoplasma hyosynoviae; swine pneumonia caused by Pasteurella spp; swine erysipelas caused by Erysipelothrix rhusiopathiae; swine dysentery associated with Treponema hyodysenteriae when followed by appropriate medication in the drinking water and/or feed.
Each mL contains 200 mg of Tylogran WSP 100% activity (as Tylogran WSP 100% base) in 50 percent propylene glycol with 4 percent benzyl alcohol and water for injection.
Injection is administered intramuscularly.
BEEF CATTLE AND NON-LACTATING DAIRY CATTLE-Inject intramuscularly 8 mg per pound of body weight one time daily (1 mL per 25 pounds).Treatment should be continued 24 hours following remission of disease signs, not to exceed 5 days. Do not inject more than 10 mL per site.
SWINE-Inject intramuscularly 4 mg per pound of body weight (1 mL per 50 pounds) twice daily. Treatment should be continued 24 hours following remission of disease signs, not to exceed 3 days. Do not inject more than 5 mL per site.
Read accompanying directions fully before use.

ADMINISTRATION AND DOSAGE:

Tylogran WSP 100% 200 Injection is administered intramuscularly.
BEEF CATTLE AND NON-LACTATING DAIRY CATTLE-Inject intramuscularly 8 mg per pound of body weight one time daily (1 mL per 25 pounds).Treatment should be continued 24 hours following remission of disease signs, not to exceed 5 days. Do not inject more than 10 mL per site.
SWINE-Inject intramuscularly 4 mg per pound of body weight (1 mL per 50 pounds) twice daily. Treatment should be continued 24 hours following remission of disease signs, not to exceed 3 days. Do not inject more than 5 mL per site.
Read accompanying directions fully before use.